Malignant Urinary Tract Neoplasm — Trials

Malignant Urinary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,954 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 507
Recruiting: 271
Ph III recruiting: 36
Growth YoY: +22.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (246)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05180851	Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01)	unknown	Early Phase 1	28	Shanghai Fengxian District Central HospitalOTHER	1	Feb 1, 2022	clinicaltrials

Data updated 22 days agoSource updated Feb 1, 2022source: clinicaltrials